Design Therapeutics, Inc. DSGN Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s shares (basic)?
- Design Therapeutics, Inc. (DSGN) reported shares (basic) of 61.4M in Q1 2026.
- How has Design Therapeutics, Inc.'s shares (basic) changed year-over-year?
- Design Therapeutics, Inc.'s shares (basic) increased by 8.2% year-over-year, from 56.8M to 61.4M.
- What is the long-term trend for Design Therapeutics, Inc.'s shares (basic)?
- Over 3 years (2022 to 2025), Design Therapeutics, Inc.'s shares (basic) has grown at a 0.8% compound annual growth rate (CAGR), from 222.7M to 227.9M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.